arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Social Sciences · Geography, Planning and Development

HUMAN BRAIN SAMPLES AND THE C. ELEGANS WORM SUGGEST A BENEFICIAL ROLE FOR A PRESENILIN-1 PROTEIN SPLICE VARIANT IN ALZHEIMER’S DISEASE, IN AGING, AND IN CALORIC RESTRICTION

Almendariz Palacios, Carla

· University Library (University of Saskatchewan)

See on the map

Abstract

Alzheimer’s disease (AD) is the most prevalent form of dementia, with projections indicating that nearly 1 million Canadians are expected to be affected by 2030. AD is classified into two types: late-onset (LOAD) and early-onset (EOAD), with EOAD occurring before the age of 60. Fewer than 5% of EOAD cases are associated with autosomal mutations, such as those in the amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) genes, leaving the causes of non-Mendelian EOAD cases largely unclear. The presenilin-1 protein (PS-1) serves as the catalytic core of the γ-secretase (GS) complex, which is responsible for processing several proteins, including APP. The processing of APP results in the formation of beta-amyloid peptide (Aβ). Variants in PS-1, including alternative splicing of the PSEN1 transcript, have been linked to EOAD. A variant carrying a deletion of four codons (corresponding to amino acids VRSQ) has also been linked to EOAD, but its precise role in the cellular biology of AD is still not fully understood. Mutations in PS-1 can exacerbate AD-related APP phenotypes and have also been associated with premature aging phenotypes. The primary objective of this thesis was to investigate the potential effects of PS-1 VRSQ on both phenotypes, utilizing human samples (to study the APP phenotype) as well as Caenorhabditis elegans (C. elegans) as an in vivo model organism for the study of aging. Furthermore, this thesis project explored the impact of tools known to influence lifespan, e.g. the caloric restriction mimetics (CRms) metformin and resveratrol, on the influence of any PS-1 VRSQ phenotype in C. elegans, providing insights into their combined impact on longevity and health. The first investigation presented in Chapter 3 examined the levels of detection of the PS-1 VRSQ protein in brain samples from neurologically normal ‘control’ individuals and in samples from individuals diagnosed with either EOAD or LOAD. The findings revealed that PS-1 VRSQ is present in both control and AD brains. Notably, the detection levels of PS-1 ΔVRSQ demonstrated a correlation with a later age of onset or a longer duration of the disease, suggesting that PS-1 ΔVRSQ may confer some benefit to the brain. However, paradoxically, I also noted that elevated levels of PS-1 ΔVRSQ were positively associated with an increased Aβ42/Aβ40 ratio, which is often used as a proxy for Aβ burden and disease severity, along with a decrease in the (Aβ38+Aβ40)/Aβ42 ratio. This latter ratio is an adaptation of the recently proposed (Aβ37+Aβ38+Aβ40)/(Aβ42+ Aβ43) ratio, which serves as a valid measure of PS-1 pathogenicity. It is important to note that these observations are derived from autopsy data and therefore do not allow for any causal inferences. Our investigation was initially guided by the hypothesis that PS-1 VRSQ might play a direct role in the development of AD. Indeed, our findings support this link, showing that PS-1 VRSQ correlates with increased Aβ levels. Nevertheless, this connection remains correlational, and its causal nature has yet to be established, prompting further inquiry into the broader implications of PS-1 VRSQ. To investigate phenotypes associated with PS-1 VRSQ without biasing outcomes towards Aβ-related pathologies, I conducted a series of experiments (Chapter 4), where I expressed PS-1 WT and PS-1 VRSQ in the hermaphroditic nematode, C. elegans. This model organism is commonly utilized for aging studies and notably lacks the APP gene, thereby preventing the production of Aβ peptides. Worm lines stably expressing human PS-1 WT and PS-1 VRSQ were developed across various genetic backgrounds. PS-1 VRSQ exerted ambiguous effects on rescue of the sel-12(ar131) defective mutant (carries a defective SEL-12, the worm ortholog of PS-1). In the N2 (control) background, PS-1 VRSQ showed an anti-aging effect, which was enhanced in 5'-fluorodeoxyuridine (FUdR)-treated worms to prevent egg hatching (a phenotype ofte

More like this